Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: Negative results of a case-control study

Journal of the American College of Cardiology

Volumn 35, Issue 1, 2000, Pages 112-118

  Hoffmeister, Albrecht ^a   Rothenbacher, Dietrich ^a   Wanner, Peter ^a   Bode, Guenter ^a   Persson, Kenneth ^b   Brenner, Hermann ^a   Hombach, Vinzenz ^a   Koenig, Wolfgang ^a  

^a UNIVERSITY OF ULM   (Germany)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; IMMUNOGLOBULIN G ANTIBODY; LIPOPOLYSACCHARIDE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATHEROGENESIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PLASMA VISCOSITY; PRIORITY JOURNAL; SERODIAGNOSIS;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0033955129     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00507-0     Document Type: Article

References (31)

1. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease is there a link? Lancet. 350:1997;430-436.
2. Libby P., Egan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis an assessment of the evidence and need for future research . Circulation. 96:1997;4095-4103.
3. Mehta J.L., Saldeen T.G.P., Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol. 31:1998;1217-1225.
4. Saikku P., Leinonen M., Mattila K.J., et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986.
5. Saikku P., Leinonen M., Tenkanen L., et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 116:1992;273-278.
6. Patel P., Mendall M.A., Carrington D., et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J. 311:1995;711-714.
7. Thom D.H., Wang S.P., Grayston J.T., et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb. 11:1991;547-551.
8. Thom D.H., Grayston J.T., Siscovick D.S., et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 268:1992;68-72.
9. Mendall M.A., Carrington D., Strachan D., et al. Chlamydia pneumoniae risk factors for seropositivity and association with coronary heart disease . J Infect. 30:1995;121-128.
10. Maass M., Gieffers J. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol Infect Dis. 6:1996;65-70.
11. Shor A., Kuo C.C., Platton D.L. Detection of Chlamydia pneumoniae in coronary artery fatty streaks and atheromatous plaques. S Afr Med J. 82:1992;158-161.
12. Kuo C., Shor A., Campbell L.A., et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 167:1993;841-849.
13. Muhlestein J.B., Hammond E.H., Carlquist J.F., et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 27:1996;1555-1561.
14. Ramirez J.A. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med. 125:1996;979-982.
15. Patel P., Carrington D., Strachan D.P., et al. Fibrinogen a link between chronic infection and coronary heart disease . Lancet. 343:1994;1634-1635.
16. Brade L., Brunnemann H., Ernst M., et al. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunol Med Microbiol. 8:1994;27-41.
17. Brade L., Holst O., Kosma P., et al. Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide. Infect Immun. 58:1990;205-213.
18. Persson K., Treharne J. Diagnosis of infections caused by Chlamydia pneumoniae strain TWAR in patients with "ornithosis" in southern Sweden 1981-1987. Scand J Infect Dis. 21:1989;675-679.
19. Harkness J. A new method for the measurement of plasma viscosity. Lancet. ii:1963;280-281.
20. Miettinen H., Lehto S., Saikku P., et al. Association of Chlamydia pneumoniae and acute coronary heart disease in non-insulin-dependent diabetic and non-diabetic subjects in Finland. Eur Heart J. 17:1996;682-688.
21. Kark J.D., Leinonen M., Paltiel O., Saikku P. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. Int J Epidemiol. 26:1997;730-738.
22. Ridker P.M., Kundsin R.B., Stampfer M.J., Poulin S., Hennekens C.H. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation. 99:1999;1161-1164.
23. Anderson J.L., Carlquist J.F., Muhlestein J.B., Horne B.J., Elmer S.P. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol. 32:1998;35-41.
24. Grayston J.T., Kuo J.-J., Campbell L.A., Benditt E.P. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur Heart J. 14:(SupplK):1993;66-71.
25. Leinonen M. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J. 14:(SupplK):1993;57-61.
26. Hahn D.L., Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscler Thromb. 12:1992;945-947.
27. Parmley W.W. Prevalence and clinical significance of silent myocardial ischemia. Circulation. 80:(Suppl IV):1989;68-73.
28. Verkooyen R.P., van Lent N.A., Mousavi Joulandan S.A., et al. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by microimmunofluorescence and ELISA. J Med Microbiol. 46:1997;961-966.
29. Maass M., Bartels C., Engel P.M., Mamat U., Sievers H.H. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 31:1998;827-832.
30. Muhlestein J.B., Anderson J.L., Hammond E.H., et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 97:1998;633-636.
31. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease meta-analyses of prospective studies . JAMA. 279:1998;1477-1482.